Stacey S Cofield Selected Research

Stacey S Cofield Research Topics

Disease

11	Rheumatoid Arthritis 11/2021 - 09/2012
8	Multiple Sclerosis 08/2021 - 03/2013
5	Hypertension (High Blood Pressure) 01/2022 - 02/2007
3	Relapsing-Remitting Multiple Sclerosis 11/2017 - 03/2013
2	Infections 01/2020 - 04/2016
2	Obstructive Sleep Apnea 08/2010 - 02/2007
2	Hyperaldosteronism (Conn Syndrome) 08/2010 - 10/2007
1	Psoriatic Arthritis 11/2021
1	Chickenpox 11/2021
1	Cognitive Dysfunction 04/2017
1	Fatigue 04/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Necrosis 10/2016
1	Rheumatic Diseases (Rheumatism) 10/2016
1	Progressive Multifocal Leukoencephalopathy 09/2016
1	Substance-Related Disorders (Drug Abuse) 04/2016
1	HIV Infections (HIV Infection) 04/2016
1	Inflammation (Inflammations) 07/2015
1	Apnea 08/2010
1	Shock 10/2008
1	Heart Arrest (Cardiac Arrest) 10/2008
1	Sleep Wake Disorders 02/2007

Drug/Important Bio-Agent (IBA)

7	Etanercept (Enbrel)FDA Link 11/2021 - 09/2012
7	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 09/2012
6	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2016 - 09/2012
6	Sulfasalazine (Azulfidine)FDA LinkGeneric 03/2016 - 09/2012
4	AldosteroneIBA 01/2012 - 02/2007
4	ReninIBA 01/2012 - 02/2007
3	Glatiramer Acetate (Copaxone)FDA Link 11/2017 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2017
2	Tumor Necrosis Factor InhibitorsIBA 11/2021 - 10/2016
2	InterferonsIBA 11/2017 - 03/2013
2	Interferon beta-1a FDA Link 11/2017 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 12/2012
1	ORALIT (ORS)IBA 01/2022
1	Herpes Zoster VaccineIBA 11/2021
1	Infliximab (Remicade)FDA Link 11/2021
1	VaccinesIBA 11/2021
1	Adalimumab (Humira)FDA Link 11/2021
1	golimumab FDA Link 11/2021
1	CytokinesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	HDL LipoproteinsIBA 01/2017
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2017
1	oligomycin sensitivity-conferring protein (complex V)IBA 01/2017
1	SynucleinsIBA 01/2017
1	Interferon Type IIBA 10/2016
1	Biological ProductsIBA 10/2016
1	Natalizumab (Tysabri)FDA Link 09/2016
1	Crack CocaineIBA 04/2016
1	CholesterolIBA 03/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015
1	Antirheumatic Agents (DMARD)IBA 08/2013
1	Lipoproteins (Lipoprotein)IBA 06/2013
1	LipidsIBA 06/2013
1	CotinineIBA 12/2012
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2012
1	SodiumIBA 10/2007

Therapy/Procedure

16	Therapeutics 11/2021 - 01/2012
1	Immunomodulation 11/2021
1	Self-Help Devices (Assistive Technology) 04/2017
1	Condoms (Condom) 04/2016
1	Cardiopulmonary Resuscitation (CPR) 10/2008